Published in J R Coll Physicians Lond on January 01, 1987
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic. Br J Gen Pract (1993) 4.89
Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol (1995) 2.58
Evaluation of computerized decision support for oral anticoagulation management based in primary care. Br J Gen Pract (1996) 1.83
Referral of patients to an anticoagulant clinic: implications for better management. Qual Health Care (1993) 1.02
Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement. J Thromb Thrombolysis (1998) 0.86
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens (2004) 8.32
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet (1998) 3.41
Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. Br J Gen Pract (1994) 1.92
Efficacy of anticoagulation in the U.K. Lancet (1981) 1.58
Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol (1993) 1.52
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49
Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet (1986) 1.35
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens (1988) 1.31
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine. Br J Clin Pharmacol (1983) 1.17
Policies for managing hypertensive patients: a survey of the opinions of British specialists. J Hum Hypertens (1990) 1.14
Rheumatoid nodule of pharynx. Br Med J (1977) 1.12
Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens (1999) 1.08
Bumetanide and frusemide: a comparison of dose-response curves in healthy men. Br J Clin Pharmacol (1978) 1.02
Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol (2005) 0.97
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens (1992) 0.94
Hemodynamic effects of a single moderate dose of alcohol in elderly subjects. J Stud Alcohol (1991) 0.90
An unusual presentation of opportunistic mucormycosis. Br Med J (Clin Res Ed) (1981) 0.88
Steady-state relative potency of aldosterone antagonists: spironolactone and prorenoate. Clin Pharmacol Ther (1981) 0.86
Clinical pharmacology and therapeutics in a changing world. Br J Clin Pharmacol (1999) 0.85
Activity of sulfur-containing intermediate metabolites of spironolactone. Clin Pharmacol Ther (1980) 0.83
Successful pregnancy following bone marrow transplantation for leukaemia. Bone Marrow Transplant (1990) 0.82
Idiopathic haemochromatosis in a young female with amenorrhoea. J R Soc Med (1989) 0.82
Relative potency of amiloride and spironolactone in healthy man. Clin Pharmacol Ther (1982) 0.82
Patient knowledge about diuretic prescription. Br J Clin Pharmacol (1993) 0.81
Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparison. Clin Pharmacol Ther (1981) 0.81
Spironolactone dose-response relationships in healthy subjects. Br J Clin Pharmacol (1982) 0.80
A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects. Br J Clin Pharmacol (1993) 0.80
Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man. Br J Clin Pharmacol (1988) 0.80
How far to lower blood pressure? Lancet (1987) 0.80
Is cancer related to hypertension or to its treatment? Clin Exp Hypertens (1999) 0.80
Cardiotoxicity and diuretics: much speculation--little substance. J Hypertens (1992) 0.80
Therapeutic drug monitoring-an hypothesis still in need of testing. Br J Clin Pharmacol (1990) 0.80
Effect of micronization on the bioavailability and pharmacologic activity of spironolactone. J Clin Pharmacol (1982) 0.79
Dose-response relationships for spironolactone at steady state. Clin Pharmacol Ther (1982) 0.79
Mechanical stretch increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells. J Hypertens (1994) 0.79
Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic. Clin Pharmacol Ther (1983) 0.79
Comparison of prorenoate potassium and spironolactone after repeated doses and steady state plasma levels of active metabolites. Br J Clin Pharmacol (1982) 0.78
Cancer risk of hypertensive patients taking calcium antagonists. J Hypertens (1998) 0.78
Effect of simple short term dietary control on urine electrolyte excretion in normal men. Clin Sci (Lond) (1986) 0.78
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan. Transplant Proc (1989) 0.78
Effects of a single moderate dose of alcohol on blood pressure, heart rate and associated metabolic and endocrine changes. Clin Sci (Lond) (1987) 0.78
Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency. Br J Clin Pharmacol (1981) 0.78
Investigation of the mechanism of beta 2-agonist-induced activation of the renin-angiotensin system. Clin Sci (Lond) (1995) 0.78
Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic. Br J Clin Pharmacol (1985) 0.77
Simple high-performance liquid chromatographic method for the measurement of amiloride in body fluids. J Chromatogr (1988) 0.77
Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? J Hum Hypertens (2005) 0.77
Mediastinal emphysema in marrow transplant recipients. Bone Marrow Transplant (1987) 0.77
Cardiac arrest following chlormethiazole infusion in chronic alcoholics. Postgrad Med J (1980) 0.76
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril. Br J Clin Pharmacol (1993) 0.76
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1987) 0.75
Managing hypertension. BMJ (1992) 0.75
High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study. Br J Cancer (1990) 0.75
Leukaemic relapse following Campath 1 treated bone marrow transplantation for leukaemia. Lancet (1986) 0.75
Poisoning with chlormethiazole. Br Med J (1979) 0.75
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience. Br J Clin Pharmacol (1982) 0.75
Beta blockers and verapamil: a cautionary tale. Br Med J (Clin Res Ed) (1984) 0.75
A fluorimetric assay for metolazone in urine. Br J Clin Pharmacol (1980) 0.75
Beta blockade, diuretics, and salt restriction for the management of mild hypertension. Br Med J (Clin Res Ed) (1984) 0.75
Diuretic induced hypokalaemia: relationship to dosage interval and plasma aldosterone. Br J Clin Pharmacol (1982) 0.75
Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial. Lancet (1997) 0.75
Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects. Br J Clin Pharmacol (1991) 0.75
Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations. Br J Clin Pharmacol (1983) 0.75
Trends in psychotropic prescribing in general practice and general medical patients. Postgrad Med J (1986) 0.75
Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia. Br J Clin Pharmacol (1984) 0.75
Lack of effect of spironolactone on hair shaft diameter in hirsute females. Postgrad Med J (1989) 0.75
Chlormethiazole and alcohol: a lethal cocktail. Br Med J (Clin Res Ed) (1987) 0.75
Metabolic consequences of salbutamol poisoning reversed by propranolol. Br Med J (Clin Res Ed) (1982) 0.75
The J-curve hypothesis. Lancet (1992) 0.75
Unusual presentation of pseudomonas infection. BMJ (1988) 0.75
Why not prescribe the best drugs for hypertension now? J Hum Hypertens (2003) 0.75
Association of renin-angiotensin system gene polymorphisms with antihypertensive responses to angiotensin-converting enzyme inhibition or angiotensin receptor blockade. J Hum Hypertens (2005) 0.75
Evaluation of aldosterone antagonists in healthy man. Methods Find Exp Clin Pharmacol (1982) 0.75
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why? Clin Exp Hypertens (1999) 0.75
Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients. J Hum Hypertens (2001) 0.75
Philadelphia chromosome-positive acute leukemia: morphologic and clinical correlations. Am J Hematol (1987) 0.75
Use of beta-blockade in a patient with phaeochromocytoma and asthma. Scott Med J (1992) 0.75
Twenty-four-hour blood pressure in junior medical staff. J R Coll Physicians Lond (1992) 0.75
Bumetanide and frusemide: qualitative differences [proceedings]. Br J Clin Pharmacol (1977) 0.75
Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transplant (1990) 0.75
Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension. J Hum Hypertens (2009) 0.75
Do we need more long-term outcome trials for the treatment of hypertension? J R Coll Physicians Edinb (2011) 0.75
Leukaemic relapse after Campath 1 treated bone marrow transplantation for leukaemia. Lancet (1986) 0.75
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol. J Hum Hypertens (2001) 0.75
Possible role of person-to-person transmission of Listeria infection in immunocompromised patients. Lancet (1989) 0.75
The active constituent of spironolactone after acute administration in man [proceedings]. Br J Clin Pharmacol (1980) 0.75
Bone-marrow transplant from father to son and subsequent graft from son to father. Lancet (1990) 0.75
Clinical pharmacology of verapamil. Br J Clin Pract Suppl (1988) 0.75
Diagnosis of haemoglobinopathies in West of Scotland. Scott Med J (1982) 0.75
Poisoning with chlormethiazole. Br Med J (1980) 0.75
Acute effects of cicletanine in angina pectoris. Eur J Clin Pharmacol (1993) 0.75
Twice-daily low-dose captopril in diuretic-treated hypertensives. J Hum Hypertens (1989) 0.75
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia. Am J Med (1994) 0.75
Therapeutics of hypertension in the work environment. J Soc Occup Med (1981) 0.75
Hypertension control--an old song resung. Blood Press (2004) 0.75
The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia. Transplant Proc (1989) 0.75